NRXS Neuraxis Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: NRXS

Price (delayed)

$7.25

Market cap

$89.79M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.81

Enterprise value

$83.06M

?
Relative Growth: Rel. Growth: 76
Relative Strength: Rel. Strength: 94
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 25

We are a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children. We are dedicated to advancing science with our proprietary PENFS technology, ...

Highlights
The company's quick ratio has surged by 148% YoY and by 43% QoQ
NRXS's equity has soared by 69% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://neuraxis.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of NRXS

NRXS stock price

How has the Neuraxis stock price performed over time
Intraday
2.55%
1 week
-0.55%
1 month
-12.65%
1 year
169.52%
YTD
59.69%
QTD
-2.03%

Financial performance

How have Neuraxis's revenue and profit performed over time
Revenue
$4.28M
Gross profit
$3.64M
Operating income
-$7.28M
Net income
-$7.28M
Gross margin
85%
Net margin
-170.1%
The company's revenue rose by 46% YoY and by 20% QoQ
Neuraxis's gross profit has increased by 44% YoY and by 21% from the previous quarter
The net margin has grown by 41% YoY and by 22% from the previous quarter
The operating margin is up by 35% YoY and by 23% from the previous quarter

Price vs fundamentals

How does NRXS's price correlate with its fundamentals

Growth

What is Neuraxis's growth rate over time

Valuation

What is Neuraxis stock price valuation
P/E
N/A
P/B
14.11
P/S
18.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.4
The EPS has grown by 33% YoY and by 15% from the previous quarter
NRXS's equity has soared by 69% since the previous quarter
NRXS's P/B is 20% above its last 4 quarters average of 11.5
The stock's P/S is 57% more than its last 4 quarters average of 11.5
The company's revenue rose by 46% YoY and by 20% QoQ

Efficiency

How efficient is Neuraxis business performance
Neuraxis's ROA has soared by 62% YoY and by 25% from the previous quarter
The ROS has grown by 40% YoY and by 22% from the previous quarter
The company's return on equity rose by 39% QoQ

Dividends

What is NRXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NRXS.

Financial health

How did Neuraxis financials performed over time
The total assets is 192% more than the total liabilities
The total assets has soared by 189% YoY and by 37% from the previous quarter
The company's quick ratio has surged by 148% YoY and by 43% QoQ
The debt is 94% less than the equity
The debt to equity has plunged by 96% YoY and by 50% from the previous quarter
NRXS's equity has soared by 69% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.